N/A
- Pharmaceuticals
- Neurotrophic Keratitis Treatment Market
Neurotrophic Keratitis Treatment Market
Neurotrophic Keratitis Treatment Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 - 2026
Introduction
Neurotrophic Keratitis is a rare condition, estimated to affect less than five people in ten thousand. Neurotrophic Keratitis is a degenerative corneal disease which is caused by impairment of trigeminal corneal innervation. The effects of Neurotrophic Keratitis are reduced or absent corneal sensations. This results in would healing ability of ocular surface tissues and epithelial breakdown.
Neurotrophic Keratitis leads to ulcer formation and ultimately corneal perforation. Neurotrophic Keratitis was considered as an orphan disease until recently when a novel disease got a FDA approval. In August 2018, FDA approved the first topical eye drop containing a recombinant human nerve growth factor called Cenegermin.
Traditional treatment for Neurotrophic Keratitis included conservative treatment and preservative-free artificial tears, topical antibiotics, tarsorrhaphy, botulinum-induced ptosis etc.
The drivers for Neurotrophic Keratitis treatment market are promising pipeline drugs, as extensive research to find a cure concluded that Topical substance P (SP) and insulin-like growth factor 1 (IGF-1) together help in proliferation of the corneal epithelial cells. Nerve Growth Factor, Nicergoline and Corneal neurotization are the promising treatments for Neurotrophic Keratitis.
Advances in biotechnology and laser and robotic treatment also aid in the treatment of Neurotrophic Keratitis. According to WHO, the number of people aged 60 years and older will be more than the number of children younger than 5 years by the year 2020. Growing geriatric population and necessity of cure for Neurotrophic Keratitis is driving the Neurotrophic Keratitis market with augmented with patient awareness.
Emerging innovative patterns of Neurotropic Keratitis treatment along with global distribution channels is expected to expand the of Neurotrophic Keratitis treatment market. Government approval for the treatment could be a barrier in the exponential growth graph of Neurotrophic Keratitis Treatment market during the forecast period.
The report covers exhaustive analysis on:
- Neurotrophic Keratitis Treatment Market Market Segments
- Neurotrophic Keratitis Treatment Market Market Dynamics
- Historical Actual Market Size, 2013 - 2016
- Neurotrophic Keratitis Treatment Market Market Size & Forecast 2017 to 2025
- Neurotrophic Keratitis Treatment Market Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Neurotrophic Keratitis Treatment Market Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
- China
Report Highlights:
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size Recent industry trends
- Key Competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
